One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v120.21.3747.3747
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 16, 2012 |
 Citations: 9 |
Affiliation: Oregon Health & Science University, Singapore General Hospital, Duke-NUS Medical School, Hôpital Lyon Sud, Washington University in St. Louis, SunEdison (United States), St. Eugenio Hospital, Ariadne Diagnostics (United States), Huntsman Cancer Institute, University of Utah, The University of Texas MD Anderson Cancer Center, Jena University Hospital, University of Bologna, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, Charité - Universitätsmedizin Berlin, Dana-Farber Cancer Institute, Seoul St. Mary's Hospital, Catholic University of Korea, Imperial College London, Hammersmith Hospital, South Australia Pathology, Hôpital Saint-Louis, Moffitt Cancer Center, Emory University, University of Milano-Bicocca, Azienda Ospedaliera San Gerardo, University of California, San Francisco, Centre Hospitalier Universitaire de Poitiers
Multivariate Analyses of the Clinical and Molecular Parameters Associated with Efficacy and Safety in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Treated with Ponatinib in the PACE Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
